Regulation
California DCC Emergency Rules Split Cannabis Licenses for Federal Tax Relief

California’s Department of Cannabis Control is pushing through emergency regulations that could open the door to significant federal tax savings for as many as 1,600 of the state’s cannabis retailers and microbusinesses — but only those willing to restructure how they hold their licenses.
The problem is that California’s licensing system wasn’t designed for. Most cannabis retailers in the state operate under a single license that covers both medical and adult-use sales. That made sense for years, but the DEA’s rescheduling order, effective April 28, 2026, changed the calculus: it moved state-licensed medical cannabis off the most restricted federal drug schedule, while leaving adult-use cannabis exactly where it was. The result is a hard dividing line through dual-licensed businesses, with federal tax relief and DEA registration accessible on the medical side and nothing on the adult-use side.
What the Emergency Rules Do
Under the proposed emergency regulations, a retailer or microbusiness currently holding a combined medical-and-adult-use license could split into two separate licenses — one for each designation — with those licenses held by two distinct but closely related legal entities operating at the same premises. The medical entity would then be positioned to register with the DEA without forcing the operator to abandon its adult-use revenue.
The department estimates roughly 1,600 licensed retailers and microbusinesses hold dual-designated licenses and could be eligible. How many will actually pursue the split is unclear.
The structure comes with conditions. Shared ownership and a designated responsible party are required across both entities. Cannabis products must be physically separated on the premises and tracked separately in inventory records. Business records must be maintained individually for each license. Both entities are jointly and severally liable for obligations and violations under either license.
The DCC opted for the emergency rulemaking process because California medical operators face a 60-day window to apply for DEA registration under the federal expedited process — a timeline that makes standard rulemaking functionally useless. Public comments on the emergency rules run from May 27, 2026, through May 31, 2026, and were submitted to California’s Office of Administrative Law with the DCC copied.
The Tax Picture Driving This
The federal tax implications are at the core of what’s at stake. For years, a federal rule disallowing ordinary business deductions for companies trafficking in Schedule I or II controlled substances applied to the entire cannabis industry — forcing operators to pay taxes on gross revenue rather than actual profit, with only the cost of goods sold deductible. Moving medical cannabis to Schedule III turns that rule off for qualifying medical operators.
Treasury and the IRS announced, following the April rescheduling, that expected guidance would include a transition rule applying that relief for the full 2026 calendar year for qualifying operators — not just the period after the April 28, 2026, effective date. For calendar-year taxpayers, that means the deduction bar is effectively gone for the entire 2026 return, unlocking wages, rent, utilities, and standard operating expenses that have been off-limits for years.
Adult-use operators see none of that. The deduction bar still applies in full to recreational cannabis sales, and the split-license structure doesn’t change that math. Dual-license operators that pursue the separation will be running two distinct tax situations under one roof.
DCC Director Clint Kellum noted in the department’s licensee notice that the agency continues to seek meetings with the federal offices leading the rescheduling implementation but has not received guidance beyond what is publicly available — a frank acknowledgment that California is moving ahead with meaningful regulatory decisions in conditions of genuine federal ambiguity.
What Comes Next
This is the second round of DCC action since the federal rescheduling. In the weeks after the April 28, 2026, order, the department removed several initial barriers for operators seeking to shift or add a medical designation, including letting cultivation licensees change their designation outside of renewal cycles and dropping the requirement for new local authorization when switching to or adding a medical designation. The emergency rules build on that foundation by offering the more complex structural pathway that dual-licensed retailers need.
Beyond California, the DEA has been expanding its registration rollout beyond the initial dispensary form, adding forms for manufacturing, distribution, and testing businesses. The broader federal rescheduling proceeding covering adult-use cannabis — which would collapse the medical-versus-recreational split in federal treatment — is expected to begin this summer.












